Seongmin Noh
Research Subjects
Seongmin Noh has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Wonkyu Hong
Human Skin Clinical Trial Center Co., Ltd., Seoul 08591, Republic of Korea
2 shared publications Byung Woo Hwang
R&D Center LG Household & Health Care (LG H&H) Seoul Republic of Korea
1 shared publication- Da Wan Kim
Department of Electronic Engineering Korea National University of Transportation Chungju‐si Republic of Korea
1 shared publication Do Young Rhee
Department of Dermatology Heal House Dermatology Seoul Republic of Korea
1 shared publication- Dong‐Hyun Ko
R&D Center LG Household & Health Care (LG H&H) Seoul Republic of Korea
1 shared publication - Hosung Choi
PIENA Aesthetic Medical Clinic, Seoul 06136, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 25 August 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (9) , e71129
A Prospective, Active‐Controlled Split‐Face Clinical Trial Evaluating the Incremental Aesthetic Benefits of a Glutathione‐Containing Booster in a GHK ‐Conjugated Spicule Regimen
Background: Transdermal delivery of hydrophilic peptides such as GHK remains limited by the stratum corneum barrier and the classical 500 Da rule. Spicule‐based systems and redox‐responsive linkages have been investigated as strategies to enhance epidermal delivery, but in vivo glutathione‐triggered cleavage remains a proposed mechanism rather than a clinically proven process. Objectives: This study aimed to evaluate the clinical efficacy and safety of a GHK‐conjugated spicule regimen and to determine whether adding a multi‐ingredient, glutathione‐containing booster provides incremental aesthetic benefit compared with the shared base regimen alone. Methods: In this prospective, active‐controlled split‐face clinical trial, 20 healthy Asian women received five weekly facial treatments. One prespecified facial side received the base regimen consisting of a GHK‐conjugated spicule system and base concentrate, while the contralateral side received the same base regimen plus a separate multi‐ingredient booster containing 1% glutathione. Wrinkle depth, pore parameters, skin elasticity, dermal density, surface roughness, and pigmentation were evaluated at baseline, after one and three treatment sessions, and 4 weeks after the fifth session. Between‐side comparisons were performed using change‐from‐baseline values, with prespecified primary endpoints, multiplicity adjustment, and effect‐size reporting. Results: Both sides showed improvements from baseline. At the final timepoint, the intensive regimen produced greater improvements than the base regimen in periorbital wrinkle depth (−0.0144 vs. −0.0084 mm), nasolabial wrinkle depth (−0.0227 vs. −0.0173 mm), dermal density (+7.27 vs. +4.49), roughness (−1.23 vs. −0.73 μm), and mean pore volume (−0.0007 vs. −0.0005 mm 3 ). Multiplicity‐adjusted between‐side differences remained significant for the prespecified primary endpoints and secondary endpoints. No adverse effects were reported. Conclusion: The GHK‐conjugated spicule base regimen improved multiple facial aging indicators, and the booster‐inclusive intensive regimen produced statistically greater short‐term improvements in this small split‐face trial. Because the booster was multi‐ingredient and the release mechanism was not directly measured in vivo, these findings should be interpreted as regimen‐level clinical evidence rather than proof of glutathione‐specific redox cleavage. Trial Registration: TRN Registration Number: PRE20250909‐005
- 25 August 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (9) , e71129
Open AccessA Prospective, Active‐Controlled Split‐Face Clinical Trial Evaluating the Incremental Aesthetic Benefits of a Glutathione‐Containing Booster in a GHK ‐Conjugated Spicule Regimen
Background: Transdermal delivery of hydrophilic peptides such as GHK remains limited by the stratum corneum barrier and the classical 500 Da rule. Spicule‐based systems and redox‐responsive linkages have been investigated as strategies to enhance epidermal delivery, but in vivo glutathione‐triggered cleavage remains a proposed mechanism rather than a clinically proven process. Objectives: This study aimed to evaluate the clinical efficacy and safety of a GHK‐conjugated spicule regimen and to determine whether adding a multi‐ingredient, glutathione‐containing booster provides incremental aesthetic benefit compared with the shared base regimen alone. Methods: In this prospective, active‐controlled split‐face clinical trial, 20 healthy Asian women received five weekly facial treatments. One prespecified facial side received the base regimen consisting of a GHK‐conjugated spicule system and base concentrate, while the contralateral side received the same base regimen plus a separate multi‐ingredient booster containing 1% glutathione. Wrinkle depth, pore parameters, skin elasticity, dermal density, surface roughness, and pigmentation were evaluated at baseline, after one and three treatment sessions, and 4 weeks after the fifth session. Between‐side comparisons were performed using change‐from‐baseline values, with prespecified primary endpoints, multiplicity adjustment, and effect‐size reporting. Results: Both sides showed improvements from baseline. At the final timepoint, the intensive regimen produced greater improvements than the base regimen in periorbital wrinkle depth (−0.0144 vs. −0.0084 mm), nasolabial wrinkle depth (−0.0227 vs. −0.0173 mm), dermal density (+7.27 vs. +4.49), roughness (−1.23 vs. −0.73 μm), and mean pore volume (−0.0007 vs. −0.0005 mm 3 ). Multiplicity‐adjusted between‐side differences remained significant for the prespecified primary endpoints and secondary endpoints. No adverse effects were reported. Conclusion: The GHK‐conjugated spicule base regimen improved multiple facial aging indicators, and the booster‐inclusive intensive regimen produced statistically greater short‐term improvements in this small split‐face trial. Because the booster was multi‐ingredient and the release mechanism was not directly measured in vivo, these findings should be interpreted as regimen‐level clinical evidence rather than proof of glutathione‐specific redox cleavage. Trial Registration: TRN Registration Number: PRE20250909‐005
- Open Access
- 15 July 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (7) , e71074
A Pilot Clinical Study of a Biomimetic Suction Patch for Improving Wrinkles, Elasticity, Hydration, and Pigmentation via Enhanced Topical Delivery
Background: Suction‐based bioinspired patches have emerged as noninvasive platforms for enhancing topical delivery; however, clinical validation of their multidimensional skin benefits remains limited. Aims: This pilot study evaluated the clinical efficacy of a biomimetic suction‐type microstructured patch combined with a cosmetic ampule for improving wrinkles, elasticity, hydration, and pigmentation. Patients/Methods: Ten healthy female subjects (aged 31–63 years) participated in a 4‐week split‐face study. The test side received both ampule and suction‐type patch application, while the control side received ampule alone. Wrinkle depth was assessed using Antera 3D, elasticity using Ballistometer (CoR), hydration using Epsilon E100, and pigmentation using DermaVision imaging. Measurements were performed at baseline, 2 weeks, and 4 weeks under controlled environmental conditions. Results: After 2 weeks, the test side showed significant improvements in wrinkle depth (−10.74% vs. −6.27%), elasticity (+4.11% vs. +2.03%), and hydration (+28.63% vs. +11.24%) compared with control. After 4 weeks, pigmentation decreased by 15.77% in the test group versus 4.99% in control. Intergroup differences were statistically significant ( p < 0.05). No adverse events were observed. Conclusions: The suction‐type biomimetic patch significantly enhanced multiple skin parameters compared with ampule application alone. These findings support the potential of structure‐mediated, noninvasive suction interfaces as delivery‐enhancing platforms in cosmetic dermatology.
- 15 July 2026
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 25 (7) , e71074
Open AccessA Pilot Clinical Study of a Biomimetic Suction Patch for Improving Wrinkles, Elasticity, Hydration, and Pigmentation via Enhanced Topical Delivery
Background: Suction‐based bioinspired patches have emerged as noninvasive platforms for enhancing topical delivery; however, clinical validation of their multidimensional skin benefits remains limited. Aims: This pilot study evaluated the clinical efficacy of a biomimetic suction‐type microstructured patch combined with a cosmetic ampule for improving wrinkles, elasticity, hydration, and pigmentation. Patients/Methods: Ten healthy female subjects (aged 31–63 years) participated in a 4‐week split‐face study. The test side received both ampule and suction‐type patch application, while the control side received ampule alone. Wrinkle depth was assessed using Antera 3D, elasticity using Ballistometer (CoR), hydration using Epsilon E100, and pigmentation using DermaVision imaging. Measurements were performed at baseline, 2 weeks, and 4 weeks under controlled environmental conditions. Results: After 2 weeks, the test side showed significant improvements in wrinkle depth (−10.74% vs. −6.27%), elasticity (+4.11% vs. +2.03%), and hydration (+28.63% vs. +11.24%) compared with control. After 4 weeks, pigmentation decreased by 15.77% in the test group versus 4.99% in control. Intergroup differences were statistically significant ( p < 0.05). No adverse events were observed. Conclusions: The suction‐type biomimetic patch significantly enhanced multiple skin parameters compared with ampule application alone. These findings support the potential of structure‐mediated, noninvasive suction interfaces as delivery‐enhancing platforms in cosmetic dermatology.